Molecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China

BMC Microbiology

Yuanyuan Dai²  Huaiwei Lu²  Xin Zhou²  Wenjiao Chang²  Xiaoling Ma²  Wulin Shan²  Wenjing Zhou¹ 

[1] Department of Laboratory Medicine, Anhui Provincial Hospital, Hefei, China;Anhui Medical University, Hefei, 230032, People’s Republic of China

关键词: MLST;    rpoB gene;    Rifampicin resistance;    MRSA;    Staphylococcus aureus;   

Others  :  1221702
DOI  :  10.1186/1471-2180-12-240

 received in 2012-07-18, accepted in 2012-10-12,  发布年份 2012

【 摘 要 】

Background

Staphylococcus aureus (S. aureus) is a major nosocomial pathogen that causes a variety of infections and toxicoses. In recent years, the percentage of rifampicin-resistant S. aureus has increased rapidly in China. The aims of this study were to analyze 1) the level of rifampicin resistance in S. aureus and its correlation with mutations in the rpoB gene, and 2) the molecular characterization of rifampicin-resistant S. aureus isolates.

Results

88 rifampicin-resistant S. aureus isolates were collected for this study. Of the 88 isolates, 83 (94.3%) were high-level rifampicin resistant (MIC≥8 mg/L) while the remaining 5 isolates (5.7%) had a low-level resistance to rifampicin (MIC, 2 to 4 mg/L). Four amino acid substitutions were found in the 88 isolates, which were 481His/Asn (95.5%), 466Leu/Ser (87.5%), 477Ala/Asp (6.8%) and 486Ser/Leu (4.5%) respectively. All mutations were found to be present in cluster I of the rpoB gene. The low-level resistant isolates were found to have only one mutation, while the high-level resistant isolates had at least two or more mutations. The most common multiple mutations were 481His/Asn+466Leu/Ser(92.8%,77/83). The other multiple mutations found were 481His/Asn+477Ala/Asp (6.0%,5/83), and 481His/Asn+466Leu/Ser+477Ala/Asp (1.2%,1/83). Out of 28 high-level rifampicin-resistant S. aureus isolates, three molecular types were found, namely, ST239-MRSA-III-spa t030 (25/28, 89.3%), ST239-MRSA-III-spa t021 (2/28, 7.1%), and ST239-MRSA-III-spa t045 (1/28, 3.6%).

Conclusions

Rifampicin resistance in S. aureus was closely associated with mutations in the rpoB gene. High-level rifampicin-resistant S. aureus is one of the most important features in Anhui Provincial Hospital, and high-level rifampicin resistance in S. aureus is associated with multiple mutations of rpoB gene. The prevalence of high-level rifampicin-resistant S. aureus in Anhui may be associated with the spread of the ST239-MRSA III-spa t030 clone.

【 授权许可】

   
2012 Zhou et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998, 339(8):520-532.
• [2]Deresinski S: Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005, 40(4):562-573.
• [3]Aubry-Damon H, Soussy CJ, Courvalin P: Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1998, 42(10):2590-2594.
• [4]Xiao YH, Giske CG, Wei ZQ, Shen P, Heddini A, Li LJ: Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat 2011, 14(4–5):236-250.
• [5]Hindler J: The 2008 CLSI Standard for Antimicrobial Susceptibiltiy Testing. Jan: APHL Teleconference; 2008.
• [6]Mick V, Dominguez MA, Tubau F, Linares J, Pujol M, Martin R: Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228. Spain. BMC Microbiol 2010, 10:68.
• [7]Zhang K, McClure JA, Elsayed S, Louie T, Conly JM: Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005, 43(10):5026-5033.
• [8]Koreen L, Ramaswamy SV, Graviss EA, Naidich S, Musser JM, Kreiswirth BN: spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol 2004, 42(2):792-799.
• [9]Harmsen D, Claus H, Witte W, Rothganger J, Turnwald D, Vogel U: Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003, 41(12):5442-5448.
• [10]Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG: Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38(3):1008-1015.
• [11]Wichelhaus TA, Boddinghaus B, Besier S, Schafer V, Brade V, Ludwig A: Biological cost of rifampin resistance from the perspective of Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46(11):3381-3385.
• [12]Didier JP, Villet R, Huggler E, Lew DP, Hooper DC, Kelley WL, Vaudaux P: Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance. Antimicrob Agents Chemother 2011, 55(5):1946-1952.
• [13]Chen R, Yan ZQ, Feng D, Luo YP, Wang LL, Shen DX: Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug susceptibility, outcome, and risk factors for hospital mortality. Chin Med J (Engl) 2012, 125(2):226-229.
• [14]Li J, Weinstein AJ, Yang M: [Surveillance of bacterial resistance in China (1998–1999)]. Zhonghua Yi Xue Za Zhi 2001, 81(1):8-16.
• [15]Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA: Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 2001, 104(6):901-912.
• [16]Jin DJ, Gross CA: Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 1988, 202(1):45-58.
• [17]Bolotin S, Alexander DC, Chedore P, Drews SJ, Jamieson F: Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada. J Antimicrob Chemother 2009, 64(2):263-266.
• [18]Wichelhaus TA, Schafer V, Brade V, Boddinghaus B: Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999, 43(11):2813-2816.
• [19]O'Neill AJ, Huovinen T, Fishwick CW, Chopra I: Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother 2006, 50(1):298-309.
• [20]Frenay HM, Bunschoten AE, Schouls LM, van Leeuwen WJ, Vandenbroucke-Grauls CM, Verhoef J, Mooi FR: Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism. Eur J Clin Microbiol Infect Dis 1996, 15(1):60-64.
• [21]Liu Y, Wang H, Du N, Shen E, Chen H, Niu J, Ye H, Chen M: Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. Antimicrob Agents Chemother 2009, 53(2):512-518.
• [22]Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N, Gardete S, Tavares A, Day N, Lindsay JA, et al.: Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010, 327(5964):469-474.
• [23]Ma XL, Chen FH, Zhou X, Chang WJ, Dai YY: Molecular characteristic of Staphylococcus aureus isolates in a Chinese teaching hospital. African Journal of Microbiology Research 2011, 5(19):2969-2974.
• [24]Coombs GW, Monecke S, Ehricht R, Slickers P, Pearson JC, Tan HL, Christiansen KJ, O'Brien FG: Differentiation of clonal complex 59 community-associated methicillin-resistant Staphylococcus aureus in Western Australia. Antimicrob Agents Chemother 2010, 54(5):1914-1921.
• [25]Chen H, Liu Y, Jiang X, Chen M, Wang H: Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period. Antimicrob Agents Chemother 2010, 54(5):1842-1847.